Position in NVO
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$374,459
+$92,477 QoQ
Shares Held
7,811
+1.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.21%
of 13F equity value
Holder Rank
#813
of 1,348 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southland Equity Partners LLC holds $15,588,502 across 9 Drug Manufacturers - General names. NVO ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
28,242 | $7,106,816 | |
| 2 | JNJ |
Johnson & Johnson
|
20,549 | $5,218,829 | |
| 3 | LLY |
ELI LILLY & Co
|
693 | $831,205 | |
| 4 | NVS |
Novartis AG
|
3,807 | $596,633 | |
| 5 | AMGN |
Amgen Inc
|
1,418 | $513,486 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,452 | $436,125 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
7,811 | $374,459 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,154 | $276,789 |
All Filings in NVO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $374,459 | 7,811 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $281,982 | 7,673 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $382,872 | 7,525 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $389,706 | 7,023 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $453,806 | 6,575 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $435,944 | 6,278 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $508,894 | 5,916 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $664,172 | 5,578 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $790,922 | 5,541 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $711,336 | 5,540 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $561,423 | 5,427 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $480,163 | 5,280 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $417,521 | 2,580 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $407,557 | 2,561 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $347,282 | 2,566 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $249,872 | 2,508 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $279,912 | 2,512 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $268,518 | 2,418 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $273,840 | 2,445 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $233,112 | 2,428 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $200,210 | 2,390 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||